BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34619654)

  • 1. Utility of quantitative susceptibility mapping and diffusion kurtosis imaging in the diagnosis of early Parkinson's disease.
    Tan S; Hartono S; Welton T; Ann CN; Lim SL; Koh TS; Li H; Setiawan F; Ng S; Chia N; Liu S; Mark Haacke E; King Tan E; Chew Seng Tan L; Ling Chan L
    Neuroimage Clin; 2021; 32():102831. PubMed ID: 34619654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The applied value in brain gray matter nuclei of patients with early-stage Parkinson's disease : a study based on multiple magnetic resonance imaging techniques.
    Meng H; Zhang D; Sun Q
    Head Face Med; 2023 Jun; 19(1):25. PubMed ID: 37386479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Application of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Techniques to Investigate the Effect of Iron Deposition on Microstructural Changes in the Brain in Parkinson's Disease.
    Yang L; Cheng Y; Sun Y; Xuan Y; Niu J; Guan J; Rong Y; Jia Y; Zhuang Z; Yan G; Wu R
    Front Aging Neurosci; 2022; 14():792778. PubMed ID: 35370619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
    An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
    J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.
    He N; Ling H; Ding B; Huang J; Zhang Y; Zhang Z; Liu C; Chen K; Yan F
    Hum Brain Mapp; 2015 Nov; 36(11):4407-20. PubMed ID: 26249218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive microstructural alterations in subcortical nuclei in Parkinson's disease: A diffusion magnetic resonance imaging study.
    Bai X; Zhou C; Guo T; Guan X; Wu J; Liu X; Gao T; Gu L; Xuan M; Gu Q; Huang P; Song Z; Yan Y; Pu J; Zhang B; Xu X; Zhang M
    Parkinsonism Relat Disord; 2021 Jul; 88():82-89. PubMed ID: 34147950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Provides Potential Biomarkers for Early-Stage Parkinson's Disease.
    Rong Y; Xu Z; Zhu Y; Zhang X; Lai L; Sun S; Gao M; Guo P; Zhang G; Geng Y; Ma X; Wu S; Yang L; Shen Z; Guan J
    ACS Chem Neurosci; 2022 Sep; 13(18):2699-2708. PubMed ID: 36047877
    [No Abstract]   [Full Text] [Related]  

  • 8. [Parkinson's disease: diffusion kurtosis imaging and the correlation with clinical manifestations].
    Sun YQ; Zhang Q; Jiang Z; Zhang CY; Zhang JW; Chen H; Shen JK
    Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(45):3534-3537. PubMed ID: 29275590
    [No Abstract]   [Full Text] [Related]  

  • 9. Striatal silent lacunar infarction is associated with changes to the substantia nigra in patients with early-stage Parkinson's disease: A diffusion kurtosis imaging study.
    Zhang G; Zhang Y; Zhang C; Wang Y; Ma G; Nie K; Xie H; Liu J; Wang L
    J Clin Neurosci; 2016 Nov; 33():138-141. PubMed ID: 27499120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
    Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
    Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Susceptibility Mapping in Parkinson's Disease.
    Langkammer C; Pirpamer L; Seiler S; Deistung A; Schweser F; Franthal S; Homayoon N; Katschnig-Winter P; Koegl-Wallner M; Pendl T; Stoegerer EM; Wenzel K; Fazekas F; Ropele S; Reichenbach JR; Schmidt R; Schwingenschuh P
    PLoS One; 2016; 11(9):e0162460. PubMed ID: 27598250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histogram analysis of diffusion kurtosis imaging of deep brain nuclei in Parkinson's disease with different motor subtypes.
    Wang J; Bi Q; Gong W; Zhang H; Deng M; Chen L; Wang B
    Clin Radiol; 2023 Dec; 78(12):e966-e974. PubMed ID: 37838544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron deposition in Parkinson's disease by quantitative susceptibility mapping.
    Chen Q; Chen Y; Zhang Y; Wang F; Yu H; Zhang C; Jiang Z; Luo W
    BMC Neurosci; 2019 May; 20(1):23. PubMed ID: 31117957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histogram Analysis of Quantitative Susceptibility Mapping for the Diagnosis of Parkinson's Disease.
    Zhang Y; Yang M; Wang F; Chen Y; Liu R; Zhang Z; Jiang Z
    Acad Radiol; 2022 Mar; 29 Suppl 3():S71-S79. PubMed ID: 33189552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion Kurtosis Imaging for Detection of Early Brain Changes in Parkinson's Disease.
    Guan J; Ma X; Geng Y; Qi D; Shen Y; Shen Z; Chen Y; Wu E; Wu R
    Front Neurol; 2019; 10():1285. PubMed ID: 31920913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of iron deposition in brain basal ganglia of patients with Parkinson's disease using quantitative susceptibility mapping.
    Shahmaei V; Faeghi F; Mohammdbeigi A; Hashemi H; Ashrafi F
    Eur J Radiol Open; 2019; 6():169-174. PubMed ID: 31065578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microstructure of Brain Nuclei in Early Parkinson's Disease: Longitudinal Diffusion Kurtosis Imaging.
    Welton T; Hartono S; Shih YC; Lee W; Chai PH; Chong SL; Ng SYE; Chia NSY; Choi X; Heng DL; Tan EK; Tan LCS; Chan LL
    J Parkinsons Dis; 2023; 13(2):233-242. PubMed ID: 36744346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extra-basal ganglia iron content and non-motor symptoms in drug-naïve, early Parkinson's disease.
    Kim M; Yoo S; Kim D; Cho JW; Kim JS; Ahn JH; Mun JK; Choi I; Lee SK; Youn J
    Neurol Sci; 2021 Dec; 42(12):5297-5304. PubMed ID: 33860863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility.
    Martin-Bastida A; Lao-Kaim NP; Loane C; Politis M; Roussakis AA; Valle-Guzman N; Kefalopoulou Z; Paul-Visse G; Widner H; Xing Y; Schwarz ST; Auer DP; Foltynie T; Barker RA; Piccini P
    Eur J Neurol; 2017 Feb; 24(2):357-365. PubMed ID: 27982501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative evaluation of brain iron accumulation in different stages of Parkinson's disease.
    Li KR; Avecillas-Chasin J; Nguyen TD; Gillen KM; Dimov A; Chang E; Skudin C; Kopell BH; Wang Y; Shtilbans A
    J Neuroimaging; 2022 Mar; 32(2):363-371. PubMed ID: 34904328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.